Patents
16. Nurunnabi M, Bhatt H. Laser and BCL-2 inhibitors combination to treat solid tumor.
15. Nurunnabi M, Ahsan MA, Pena JZ. Biosensor to detect risk of stomach cancer.
14. Nurunnabi M, Noveron JC, Ahsan A, Islam T. LepSens: A biosensor based POC tool to monitor obesity.
Provisional Patent# 63/370,147 (8/2/2022)
Application# 63/370,147 (8/2/2022)
13. Nurunnabi M, Afrin H. Targeted therapy for kidney fibrosis.
Application# 18/057,554 (11/21/2022), #US20230157970
12. Nurunnabi M, Huda M. Targeted Therapy of Skin fibrosis and melanoma.
US non-provisional Patent # 63/264,295 (11/19/2021)
Application# 18/057,567 (11/21/202) #US20230165806
11. Nurunnabi M, Huda M, Afrin H, Salazar CJJ. Oral antibody and protein delivery for obesity management.
US Non-provisional Patent # 63/225,477 (7/24/2021)
Application# 17/871,953 (7/24/2022), #US20230024537
Prior to UTEP
10. Huh KM, Nurunnabi M, Khatun Z, Kim YG. Sub-cellular targeting delivery systems with miktoarm polymeric carrier. Korean patent (Applied on May 2016) Assignee: Chungnam National University
9. Nurunnabi M, Lee Y, Huh KM. Boron nitride nanosheets for application in optical imaging and bionsensing. Korean patent (Applied on 8th January 2016) Application # KR1020160112312A. Assignee: Chungnam National University
8. Nurunnabi M, Rahmatullah M, Lee Y. Glucose lowering activity of a formulation containing Indian gooseberry. Korean Patent Application Application# KR1020160021886A Licensed by KB BioMed Inc (Chungju, South Korea) Assignee: Korea National University of Transportation
7. Lee Y, Nurunnabi M. Application of photoluminescent graphene for cancer photo-therapy. Applied for Korea patent. Application# KR1020140047527A. Assignee: Korea National University of Transportation
6. Lee Y, Cho KJ, Park IK, Nurunnabi M, Lee SJ, Kang SH, Liver Targeting Metal Nano-Particle Based Nucleic Acid Delivery System and Manufacturing Method Thereof. Korean Patent Application no. 2014R1A2A2A03004802, United States Patent Application 20170065724. Assignee: Korea National University of Transportation
5. Bae YH, Lee Y, Nurunnabi M, Hwang HS, Kwang D. Methods and Composition of Bile Acid Particles. Application No. PCT/US2015/058375, Licensed by Ileo Science (Utah, USA) Assignee: University of Utah
4. Lee Y, Nurunnabi M. Heparin-Docetaxel-taurocholic acid conjugate for oral anticancer drug delivery. Korean patent, Application no. KR 10-2011-0087581. Assignee: Korea National University of Transportation
3. Lee Y, Nurunnabi M. Synthetic method of near infra-red graphene quantum dots. Registration No.1014079030000 (Application no. 1020120133674) (also applied for PCT) Licensed by BioActs Inc (South Korea). Assignee: Korea National University of Transportation
2. Lee Y, Nurunnabi M, Rahmatullah M. Barley and crusted crusted rice extract a pharmaceutical composition comprising as an active ingredient. Registration no: WO2013105693 A1 (Application no. PCT/KR2012/001263) Licensed by Cheill Bio Co (South Korea. Assignee: Korea National University of Transportation
1. Lee Y, Nurunnabi M, Rahmatullah M, Pharmaceutical composition containing paddy husk and barley husk extract as activeingredient. (Korean language), Korean patent, Registration No.: 1013631110000 (Application No.: 1020120003830) Licensed by Cheill Bio Co (South Korea). Assignee: Korea National University of Transportation